Pío R - Search Results

1

Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.

Oliemuller E, Peláez R, Garasa S, Pajares MJ, Agorreta J, Pío R, Montuenga LM, Teijeira A, Llanos S, Rouzaut A. Oliemuller E, et al. Among authors: pio r. Int J Cancer. 2013 May 1;132(9):1986-95. doi: 10.1002/ijc.27881. Epub 2012 Oct 20. Int J Cancer. 2013. PMID: 23023514

2

Nitric oxide activates granule-associated DNase in human monocytes.

Pío R, López-Zabalza MJ, Rouzaut A, Santiago E, López-Moratalla N. Pío R, et al. Nitric Oxide. 1998;2(3):165-73. doi: 10.1006/niox.1998.0175. Nitric Oxide. 1998. PMID: 9731634 Free article.

3

Adrenomedullin functions as an important tumor survival factor in human carcinogenesis.

Cuttitta F, Pío R, Garayoa M, Zudaire E, Julián M, Elsasser TH, Montuenga LM, Martínez A. Cuttitta F, et al. Among authors: pio r. Microsc Res Tech. 2002 Apr 15;57(2):110-9. doi: 10.1002/jemt.10059. Microsc Res Tech. 2002. PMID: 11921362 Free article. Review.

4

Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer.

Pino I, Pío R, Toledo G, Zabalegui N, Vicent S, Rey N, Lozano MD, Torre W, García-Foncillas J, Montuenga LM. Pino I, et al. Among authors: pio r. Lung Cancer. 2003 Aug;41(2):131-43. doi: 10.1016/s0169-5002(03)00193-4. Lung Cancer. 2003. PMID: 12871776 Free article.

5

Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.

Carretero J, Medina PP, Pio R, Montuenga LM, Sanchez-Cespedes M. Carretero J, et al. Among authors: pio r. Oncogene. 2004 May 13;23(22):4037-40. doi: 10.1038/sj.onc.1207502. Oncogene. 2004. PMID: 15021901 Free article.

6

Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer.

Pio R, Zudaire I, Pino I, Castaño Z, Zabalegui N, Vicent S, Garcia-Amigot F, Odero MD, Lozano MD, Garcia-Foncillas J, Calasanz MJ, Montuenga LM. Pio R, et al. Cancer Res. 2004 Jun 15;64(12):4171-9. doi: 10.1158/0008-5472.CAN-03-2982. Cancer Res. 2004. PMID: 15205328 Free article.

7

Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.

Ajona D, Castaño Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R. Ajona D, et al. Among authors: pio r. Cancer Res. 2004 Sep 1;64(17):6310-8. doi: 10.1158/0008-5472.CAN-03-2328. Cancer Res. 2004. PMID: 15342420

8

Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.

Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, Meyer AM, Port JD, Montuenga LM, Malkinson AM. Zerbe LK, et al. Among authors: pio r. Mol Carcinog. 2004 Dec;41(4):187-96. doi: 10.1002/mc.20053. Mol Carcinog. 2004. PMID: 15390079

9

Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features.

Pajares MJ, Zudaire I, Lozano MD, Agorreta J, Bastarrika G, Torre W, Remírez A, Pio R, Zulueta JJ, Montuenga LM. Pajares MJ, et al. Among authors: pio r. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):373-80. doi: 10.1158/1055-9965.EPI-05-0320. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492931

10

Alternative splicing: an emerging topic in molecular and clinical oncology.

Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM. Pajares MJ, et al. Among authors: pio r. Lancet Oncol. 2007 Apr;8(4):349-57. doi: 10.1016/S1470-2045(07)70104-3. Lancet Oncol. 2007. PMID: 17395108 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters